Approximately 50% of pancreatic carcinomas, 20% of colon carcinomas, and 10% of lung cancers exhibit mutations in SMAD4, and mutations in SMAD2 have been found in ~7% of colorectal and lung cancers [7,9]. The gene discussed is SMAD4; the disease is exocrine pancreatic carcinoma.